An artificial intelligence model to predict survival and chemotherapy benefits for gastric cancer patients after gastrectomy development and validation in international multicenter cohorts.
An artificial intelligence model to predict survival and chemotherapy benefits for gastric cancer patients after gastrectomy development and validation in international multicenter cohorts.
Xunjun Li,Zhong-mei Zhai,14 Authors,Tao Chen
2022 · DOI: 10.1016/j.ijsu.2022.106889
International Journal of Surgery · 23 Citations
TLDR
The SVM-based model may be used to predict OS and DFS in GC patients and the benefit of adjuvant chemotherapy in TNM stage Ⅱ and Ⅲ GC patients.